Why value assessments for innovative therapies must consider health system barriers NEW IN HEALTH AFFAIRS Bringing Systems Thinking to Drug Value Assessment Colorful knot of paper strips, with three pieces emerging in different directions pointing in arrows. Catalyst, a new educational project from NEWDIGS, publishes short, actionable briefs to help you implement innovative CGT payment strategies. BRASS TACKS Catalyst: Action-oriented references Continuous-line drawing of two hands putting puzzle pieces together Shifting the focus from drug cost to value must consider ‘health efficiency’ NEW OPED Biomedical Innovation Requires Health System Innovation Hand drawing straight line from A to B BioCentury logo Analyzing the intersecting challenges of ensuring patient access for gene therapies ICER / NEWDIGS WHITE PAPER Managing the Challenges of Paying for Gene Therapy: Strategies for Market Action and Policy Reform A needle with three threads
Balls balanced on boards despite apparent imbalance

NEW JOURNAL PUBLICATION

Managing the challenges of paying for gene therapy: strategies for market action and policy reform in the United States

New open access policy analysis from Institute for Clinical and Economic Review (ICER) and NEWDIGS Initiative at Tufts Medical Center analyzes the challenges and potential policy options for paying for gene therapies.

Read the open access paper

Recent news

Health Affairs Forefront: Bringing Systems Thinking to Drug Value Assessment

Mar 11, 2025

Mara Palm joins NEWDIGS

Jul 18, 2024

NEWDIGS leaders named to Illinois SCD Advisory Council

Jul 02, 2024

ISPOR 2024 panel recap: Will the Pediatric Rare Disease Pipeline Create a Financial Tsunami? Implications of a Monte Carlo Projection

May 21, 2024

BioCentury OpEd: Biomedical Innovation Requires Health System Innovation

May 14, 2024

Our mission is to improve health outcomes by accelerating appropriate, timely, and equitable patient access to biomedical products in ways that work for all stakeholders.

We design and catalyze solutions with an integrated systems view through complementary approaches of public-private partnerships (our consortium), sponsored research, custom education, and experiential action learning.

Publications and media

Document thumbnails

Paying for Cures

Thumbnail previews of documents

Events

Image
Image

NEWDIGS Consortium

Cross-stakeholder collaboration for system-wide innovation

The NEWDIGS Consortium focuses on improving patients’ healthcare outcomes by accelerating appropriate and timely access to biomedical products in ways that are sustainable by all stakeholders.

NEWDIGS IMPACT

Bringing system innovation to your organization

NEWDIGS IMPACT offers flexible and custom-designed programs to engage your organization’s strategists and decision makers in system innovations that your organization can adopt.

Image

Research

Collaborations for groundbreaking strategy

Partner with CBSD to explore novel strategies to address urgent and emerging challenges in healthcare innovation, and produce new ideas to help all stakeholders. 

Image
Image

Education

Targeted and customizable programs

Our educational programs help organizations address complex healthcare innovation problems, enhance understanding of strategic topic areas, build organizational capacity for cross-functional design, pressure test solutions with an integrated systems view, and more.

Real-world applications

Putting system redesign concepts to work

CBSD helps distributed innovation and research networks build capacity through customized programs focused on real-world change initiatives.

Hands of five hospital clinicians putting puzzle pieces together